Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Anemia

Free Subscription Articles published in Transfusion Retrieve available abstracts of 95 articles: HTML format

Single Articles

March 2023
1. JUTRAS C, Sauthier M, Tucci M, Trottier H, et al
   Prevalence and determinants of anemia at discharge in pediatric intensive care survivors.
   Transfusion. 2023 Mar 12. doi: 10.1111/trf.17309.
   PubMed     Abstract available
   
   
   February 2023
2. DAVIES AT, Devlin PM, Dugan C, Richards T, et al
   Non-erythropoiesis stimulating agent, non-iron therapies for the management of anemia: A scoping review.
   Transfusion. 2023 Feb 22. doi: 10.1111/trf.17274.
   PubMed    
   
   
   
3. DELAFORCE A, Farmer S, Duff J, Munday J, et al
   Results from a type two hybrid-effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway.
   Transfusion. 2023 Feb 21. doi: 10.1111/trf.17287.
   PubMed     Abstract available
   
   
   
4. GHESQUIERE L, Leroy J, Deken V, Tournier A, et al
   Anti-RH1 alloimmunization: At what maternal antibody threshold is there a risk of severe fetal anemia?
   Transfusion. 2023 Feb 3. doi: 10.1111/trf.17264.
   PubMed     Abstract available
   
   
   
5. TRAN A, Yan MTS, Branch DR, Blacquiere M, et al
   Severe fetal anemia caused by anti-Jr(a) : Burst forming unit-erythroid colony formation inhibition assay suggesting possible erythroid suppression mechanism.
   Transfusion. 2023 Feb 2. doi: 10.1111/trf.17265.
   PubMed     Abstract available
   
   
   
6. ALSAGHIR A, Alsaghir L, Alsaif J, Mobeireek A, et al
   Successful therapeutic plasma exchange for a patient with sickle cell disease and fat embolism syndrome after a failure of a response to red cell exchange transfusion.
   Transfusion. 2023;63 Suppl 1:S33-S36.
   PubMed     Abstract available
   
   
   
7. LENET T, Skanes S, Tropiano J, Verret M, et al
   Patient perspectives on intraoperative blood transfusion: A qualitative interview study with perioperative patients.
   Transfusion. 2023;63:305-314.
   PubMed     Abstract available
   
   
   January 2023
8. JACOBS JW, Abels E, Binns TC, Tormey CA, et al
   Warm autoimmune hemolytic anemia with anti-Jk(a) specificity following babesiosis masquerading as a delayed hemolytic transfusion reaction.
   Transfusion. 2023 Jan 17. doi: 10.1111/trf.17252.
   PubMed     Abstract available
   
   
   
9. HORNEDO-GONZALEZ KD, Jacob AK, Burt JM, Higgins AA, et al
   Non-invasive hemoglobin estimation for preoperative anemia screening.
   Transfusion. 2023 Jan 5. doi: 10.1111/trf.17237.
   PubMed     Abstract available
   
   
   December 2022
10. RINGEL F, Kiesewetter H, Mayer B, Bartolmas T, et al
    Silvernanoparticle-induced hemolysis confounded with direct antiglobulin test-negative autoimmune hemolytic anemias diagnosis.
    Transfusion. 2022;62:2648-2652.
    PubMed     Abstract available
    
    
    November 2022
11. MAISONNEUVE E, Sohier Lepine M, Maurice P, Pissard S, et al
    Prenatal management of fetal anemia due to pyruvate kinase deficiency: A case report.
    Transfusion. 2022 Nov 8. doi: 10.1111/trf.17177.
    PubMed     Abstract available
    
    
    October 2022
12. KARAFIN MS, Field JJ, Ilich A, Li L, et al
    Hypoxic storage of donor red cells preserves deformability after exposure to plasma from adults with sickle cell disease.
    Transfusion. 2022 Oct 30. doi: 10.1111/trf.17163.
    PubMed     Abstract available
    
    
    
13. TEAWTRAKUL N, Songdej D, Hantaweepant C, Tantiworawit A, et al
    Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand.
    Transfusion. 2022;62:2039-2047.
    PubMed     Abstract available
    
    
    
14. ANTHON CT, Granholm A, Sivapalan P, Zellweger N, et al
    Prophylactic platelet transfusions versus no prophylaxis in hospitalized patients with thrombocytopenia: A systematic review with meta-analysis.
    Transfusion. 2022;62:2117-2136.
    PubMed    
    
    
    
15. KRULL A, Thompson T, Strasburg D, DiGuardo M, et al
    How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease?
    Transfusion. 2022;62:1942-1947.
    PubMed     Abstract available
    
    
    
16. GERRITSMA JJ, van der Bolt N, van Bruggen R, Ten Brinke A, et al
    Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and beta-Thalassemia: A biotin label approach.
    Transfusion. 2022;62:1984-1996.
    PubMed     Abstract available
    
    
    September 2022
17. HOPKINS CK, Townsend M, Vassallo RR
    Leukoreduction filters: Still stuck on sickle trait red cells.
    Transfusion. 2022;62:1683-1687.
    PubMed    
    
    
    
18. LAURIDSEN L, Campbell-Lee SA
    Doing more with less: Patient blood management meets sickle cell disease management.
    Transfusion. 2022;62:1688-1692.
    PubMed    
    
    
    
19. GEHRIE EA, Petran L, Young PP
    Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations.
    Transfusion. 2022;62:1727-1730.
    PubMed     Abstract available
    
    
    
20. JONES JM, Swett AD, Crowe EP, Lawrence C, et al
    Implementation of national blood conservation recommendations at an adult sickle cell center.
    Transfusion. 2022;62:1763-1771.
    PubMed     Abstract available
    
    
    August 2022
21. SEHEULT JN, Callum J, Delaney M, Drake R, et al
    Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
    Transfusion. 2022;62 Suppl 1:S185-S192.
    PubMed     Abstract available
    
    
    
22. COVINGTON ML, Cone-Sullivan JK, Andrzejewski C, Lu W, et al
    Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement.
    Transfusion. 2022;62:1662-1670.
    PubMed    
    
    
    July 2022
23. BADE NA, Giri U, Wang H, Ershler WB, et al
    Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center.
    Transfusion. 2022;62:1462-1464.
    PubMed    
    
    
    
24. FUJA C, Kothary V, Carll TC, Singh S, et al
    Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
    Transfusion. 2022;62:1446-1451.
    PubMed     Abstract available
    
    
    
25. HANSEN DL, Moller S, Berentsen S, Frederiksen H, et al
    Mortality in cold agglutinin disease shows seasonal pattern.
    Transfusion. 2022;62:1460-1461.
    PubMed    
    
    
    June 2022
26. KRANENBURG FJ, Arbous SM, Caram-Deelder C, Putter H, et al
    Predicting organ functioning with and without blood transfusion in critically ill patients with anemia.
    Transfusion. 2022 Jun 30. doi: 10.1111/trf.16998.
    PubMed     Abstract available
    
    
    
27. PROCHASKA M, Salcedo J, Berry G, Meltzer D, et al
    Racial differences in red blood cell transfusion in hospitalized patients with anemia.
    Transfusion. 2022 Jun 3. doi: 10.1111/trf.16935.
    PubMed     Abstract available
    
    
    May 2022
28. JOUZIER C, Cherait A, Cony-Makhoul P, Hamel JF, et al
    Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myelodysplasies (GFM).
    Transfusion. 2022;62:961-973.
    PubMed     Abstract available
    
    
    April 2022
29. CARLL T, Mei Z, Aldarweesh F, Wool GD, et al
    Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy.
    Transfusion. 2022;62:916-918.
    PubMed    
    
    
    March 2022
30. GUINN NR, Fuller M, Murray S, Aronson S, et al
    Treatment through a preoperative anemia clinic is associated with a reduction in perioperative red blood cell transfusion in patients undergoing orthopedic and gynecologic surgery.
    Transfusion. 2022 Mar 11. doi: 10.1111/trf.16847.
    PubMed     Abstract available
    
    
    
31. MEENAN J, Hall R, Badle S, Chatterjee B, et al
    Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far.
    Transfusion. 2022;62:546-550.
    PubMed     Abstract available
    
    
    
32. WADE J, Yee MEM, Easley KA, Pahz S, et al
    Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange.
    Transfusion. 2022;62:584-593.
    PubMed     Abstract available
    
    
    
33. YEE ME, Francis RO, Luban NLC, Easley KA, et al
    Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease.
    Transfusion. 2022;62:551-555.
    PubMed     Abstract available
    
    
    
34. SEEBER P, Dobel KU, Isbister JP, Murray K, et al
    Mortality and morbidity in non-transfusable and transfusable patients: A systematic review and meta-analysis.
    Transfusion. 2022;62:685-697.
    PubMed    
    
    
    February 2022
35. SCHIFFER CA
    Commentary on the prescient observations made by Emil J Freireich in Effectiveness of platelet transfusion in leukemia and aplastic anemia (Transfusion 1966; 6: 50-54).
    Transfusion. 2022;62:267-272.
    PubMed    
    
    
    January 2022
36. PATRIQUIN CJ, Pavenski K
    O, wind, if winter comes ... will symptoms be far behind?: Exploring the seasonality (or lack thereof) and management of cold agglutinin disease.
    Transfusion. 2022;62:2-10.
    PubMed    
    
    
    
37. ROTH A, Fryzek J, Jiang X, Reichert H, et al
    Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
    Transfusion. 2022;62:51-59.
    PubMed     Abstract available
    
    
    
38. KRIGSTEIN M, Cromer N
    Navigating the challenges of Bombay phenotype (Oh ) and twin pregnancy; a case report and literature review.
    Transfusion. 2022;62:247-251.
    PubMed     Abstract available
    
    
    
39. CARR NR, Henry E, Bahr TM, Ohls RK, et al
    Fetomaternal hemorrhage: Evidence from a multihospital healthcare system that up to 40% of severe cases are missed.
    Transfusion. 2022;62:60-70.
    PubMed     Abstract available
    
    
    December 2021
40. LEE ES, Hendrickson JE, Tormey CA
    RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary?
    Transfusion. 2021;61:3283-3285.
    PubMed    
    
    
    
41. KARKI S, Davison TE, Liu B, Bell K, et al
    Visits to general practitioners after iron-related deferrals from blood donation in middle-aged and older Australian blood donors.
    Transfusion. 2021;61:3335-3343.
    PubMed     Abstract available
    
    
    
42. ARNONI CP, Vendrame T, Muniz J, Cortez A, et al
    RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors.
    Transfusion. 2021;61:3473-3482.
    PubMed     Abstract available
    
    
    November 2021
43. DIANA JS, Manceau S, Leblanc T, Magnani A, et al
    A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy.
    Transfusion. 2021 Nov 9. doi: 10.1111/trf.16721.
    PubMed     Abstract available
    
    
    
44. LIOU S, Bakic L, Manakelew B, Guillermo F, et al
    False anemia due to total parenteral nutrition and lipid emulsion contamination.
    Transfusion. 2021 Nov 5. doi: 10.1111/trf.16728.
    PubMed    
    
    
    
45. HAMILTON CM, Davenport DL, Bernard AC
    Demonstration of a U.S. nationwide reduction in transfusion in general surgery and a review of published transfusion reduction methodologies.
    Transfusion. 2021;61:3119-3128.
    PubMed     Abstract available
    
    
    
46. YAMAMOTO T, Bikhet MH, Marques MB, Nguyen HQ, et al
    Initial experimental experience of triple-knockout pig red blood cells as potential sources for transfusion in alloimmunized patients with sickle cell disease.
    Transfusion. 2021;61:3104-3118.
    PubMed     Abstract available
    
    
    October 2021
47. KAMESAKI T
    Diagnostic algorithm for classification and characterization of direct antiglobulin test-negative autoimmune hemolytic anemia with 1-year clinical follow-up.
    Transfusion. 2021 Oct 19. doi: 10.1111/trf.16709.
    PubMed     Abstract available
    
    
    
48. CALLAN MB, Thawley VJ, Marryott KA, Shabro A, et al
    Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs.
    Transfusion. 2021 Oct 11. doi: 10.1111/trf.16690.
    PubMed     Abstract available
    
    
    
49. TANG CH, Furnback W, Wang BCM, Tang J, et al
    Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.
    Transfusion. 2021;61:2906-2917.
    PubMed     Abstract available
    
    
    
50. LAL A, Wong T, Keel S, Pagano M, et al
    The transfusion management of beta thalassemia in the United States.
    Transfusion. 2021;61:3027-3039.
    PubMed    
    
    
    
51. ABEL GA, Klepin HD, Magnavita ES, Jaung T, et al
    Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
    Transfusion. 2021;61:2830-2836.
    PubMed     Abstract available
    
    
    September 2021
52. GADI SRV, Brunker PAR, Al-Samkari H, Sykes DB, et al
    Severe Autoimmune Hemolytic Anemia Following Receipt of SARS-CoV-2 mRNA Vaccine.
    Transfusion. 2021 Sep 22. doi: 10.1111/trf.16672.
    PubMed     Abstract available
    
    
    
53. ANG AL, Lim CY, Ng WY, Lam JCM, et al
    Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
    Transfusion. 2021;61:2566-2577.
    PubMed     Abstract available
    
    
    
54. AVECILLA ST, Boulad F, Yazdanbakhsh K, Sadelain M, et al
    Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
    Transfusion. 2021;61:2775-2781.
    PubMed     Abstract available
    
    
    August 2021
55. TANHEHCO YC, Delgado AC
    Red blood cell reduction of a sickle cell disease stem cell product.
    Transfusion. 2021 Aug 29. doi: 10.1111/trf.16633.
    PubMed    
    
    
    
56. SALINAS CISNEROS G, Webb J, Luban NLC, Nickel RS, et al
    Impact of universal irradiation on chronic transfusion for sickle cell disease.
    Transfusion. 2021;61:2290-2294.
    PubMed     Abstract available
    
    
    
57. CHIDAMBARAM V, Jones JM, Lokhandwala PM, Bloch EM, et al
    Low rates of transfusion-transmitted infection screening in chronically transfused adults with sickle cell disease.
    Transfusion. 2021;61:2421-2429.
    PubMed     Abstract available
    
    
    
58. MUNIZ JG, Arnoni C, Medeiros R, Vendrame T, et al
    Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Transfusion. 2021;61:2458-2467.
    PubMed     Abstract available
    
    
    
59. RANKIN A, Darbari D, Campbell A, Webb J, et al
    Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Transfusion. 2021;61:2255-2264.
    PubMed     Abstract available
    
    
    July 2021
60. CAHILL CM, Alhasson B, Blumberg N, Melvin A, et al
    Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay.
    Transfusion. 2021 Jul 15. doi: 10.1111/trf.16564.
    PubMed     Abstract available
    
    
    
61. SARKER TT, Delvadia B, Li S, Roback JD, et al
    Mizuho hemoglobinopathy, presenting with severe hemolytic anemia and multisystem organ failure secondary to exertion.
    Transfusion. 2021 Jul 1. doi: 10.1111/trf.16522.
    PubMed    
    
    
    
62. HASAN RA, Asif M, Tuott EE, Stansbury LG, et al
    Rates of delayed hemolytic transfusion reactions observed in a trauma center.
    Transfusion. 2021;61:2035-2040.
    PubMed     Abstract available
    
    
    
63. GOWDA L, Vege S, Kessler D, Shaz B, et al
    Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population.
    Transfusion. 2021;61:2008-2013.
    PubMed     Abstract available
    
    
    June 2021
64. GAMBERINI MR, Fortini M, Stievano A, Calori E, et al
    Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial.
    Transfusion. 2021;61:1729-1739.
    PubMed     Abstract available
    
    
    
65. GODBEY EA, Anderson MR, M Bachmann L, Sanford KW, et al
    How do we monitor hemoglobin S in patients who undergo red blood cell exchange and take voxelotor?
    Transfusion. 2021;61:1680-1683.
    PubMed    
    
    
    
66. BAROUQA M, Szymanski J, Nelson R, Jofre S, et al
    Bone marrow necrosis and fat embolism syndrome in sickle cell disease: A rapidly deteriorating complication.
    Transfusion. 2021;61:1678-1679.
    PubMed    
    
    
    May 2021
67. ANANDAPPA AJ, Stefely JA, Hasserjian RP, Dzik WH, et al
    Multiorgan failure in a fatal case of autoimmune hemolytic anemia.
    Transfusion. 2021 May 27. doi: 10.1111/trf.16513.
    PubMed     Abstract available
    
    
    
68. LI S, He Z, Mo C, Ji Y, et al
    Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Transfusion. 2021 May 3. doi: 10.1111/trf.16350.
    PubMed     Abstract available
    
    
    
69. MCOMISH C
    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:1355-1358.
    PubMed    
    
    
    
70. GUARENTE J, Palladino M, Babariya S, Hayes C, et al
    Iatrogenic arteriovenous fistula in patient with sickle cell disease undergoing red blood cell exchange.
    Transfusion. 2021;61:1361-1362.
    PubMed    
    
    
    April 2021
71. THEMELIN N, Biston P, Massart J, Lelubre C, et al
    Effects of red blood cell transfusion on global oxygenation in anemic critically ill patients.
    Transfusion. 2021;61:1071-1079.
    PubMed     Abstract available
    
    
    
72. JUSKEWITCH JE, Murray JD, Norgan AP, Moldenhauer SK, et al
    In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levels.
    Transfusion. 2021;61:1302-1311.
    PubMed     Abstract available
    
    
    March 2021
73. NGUYEN TN, Maenulein E, Fihman V, Vinatier I, et al
    Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
    Transfusion. 2021 Mar 9. doi: 10.1111/trf.16360.
    PubMed     Abstract available
    
    
    
74. ATAGA KI, Elsherif L, Wichlan D, Wogu AF, et al
    A pilot study of the effect of rivaroxaban in sickle cell anemia.
    Transfusion. 2021 Mar 4. doi: 10.1111/trf.16343.
    PubMed     Abstract available
    
    
    February 2021
75. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    PubMed     Abstract available
    
    
    
76. DURIEUX-ROUSSEL E, Laget L, Filosa L, Izard C, et al
    RHCE*01 (c.499A>G, p.Met167Val) allele: Weak RhE expression which does not require the E-specific proline 226.
    Transfusion. 2021;61:E18-E20.
    PubMed    
    
    
    
77. ZIEMBA Y, Xu C, Fomani KM, Nandi V, et al
    Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
    Transfusion. 2021;61:526-536.
    PubMed     Abstract available
    
    
    
78. DINARDO CL, Oliveira TGM, Kelly S, Ashley-Koch A, et al
    Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Transfusion. 2021;61:603-616.
    PubMed     Abstract available
    
    
    
79. SLICHTER SJ, Gernsheimer T, LeBlanc R, Townsend-McCall D, et al
    Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Transfusion. 2021;61:393-403.
    PubMed     Abstract available
    
    
    January 2021
80. ANDERSEN LH, Jacob EK, McThenia SS, Tauscher CD, et al
    Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Transfusion. 2021 Jan 14. doi: 10.1111/trf.16252.
    PubMed     Abstract available
    
    
    
81. SPENCER BR, Fox MP, Wise LA, Cable RG, et al
    Iron status and self-reported fatigue in blood donors.
    Transfusion. 2021;61:124-133.
    PubMed     Abstract available
    
    
    
82. JUSKEWITCH JE, Zuccarelli MD, Berg HE, Summerfield DD, et al
    Transfusion medicine illustrated: When less is more for HLA antibodies.
    Transfusion. 2021;61:9-11.
    PubMed    
    
    
    
83. VASSALLO RR
    Donor iron depletion in context.
    Transfusion. 2021;61:318-321.
    PubMed    
    
    
    
84. RICHARDS AL, Qiu A, Zotti FD, Sheldon K, et al
    Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.
    Transfusion. 2021;61:225-235.
    PubMed     Abstract available
    
    
    
85. SRIVASTAVA K, Albasri J, Alsuhaibani OM, Aljasem HA, et al
    SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system.
    Transfusion. 2021;61:246-254.
    PubMed     Abstract available
    
    
    
86. SAYERS M
    Donor iron nutrition: Which precaution prevails?
    Transfusion. 2021;61:313-317.
    PubMed    
    
    
    December 2020
87. JACOBS J, Eichbaum Q
    COVID-19 associated with severe autoimmune hemolytic anemia.
    Transfusion. 2020 Dec 3. doi: 10.1111/trf.16226.
    PubMed     Abstract available
    
    
    
88. PAGANO MB, Cataife G, Fertrin KY, Gernsheimer T, et al
    Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
    Transfusion. 2020;60:2859-2866.
    PubMed     Abstract available
    
    
    October 2020
89. BEVERINA I, Scalvini R, Brando B
    "Camel humps"-shaped red blood cell histogram in a woman with extreme anemia treated with intravenous iron.
    Transfusion. 2020 Oct 28. doi: 10.1111/trf.16154.
    PubMed    
    
    
    
90. GARCIA-GARCIA I, Cid J, Palomino A, Gine E, et al
    Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports.
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16143.
    PubMed     Abstract available
    
    
    
91. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    PubMed     Abstract available
    
    
    
92. MAZZEFFI M, Taneja M, Porter S, Chow JH, et al
    Anemia, sex, and race as predictors of morbidity or mortality after knee arthroplasty surgery.
    Transfusion. 2020 Oct 5. doi: 10.1111/trf.16111.
    PubMed     Abstract available
    
    
    
93. FERGUSSON DA, Lalu MM
    Mind the evidence gap: The need for trials in the prevention and management of perioperative anemia in noncardiac surgery.
    Transfusion. 2020;60:2168-2170.
    PubMed    
    
    
    September 2020
94. SANCHEZ-DURAN MA, Higueras MT, Aviles-Garcia M, Maiz N, et al
    Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17 years' experience in a tertiary center.
    Transfusion. 2020 Sep 21. doi: 10.1111/trf.16087.
    PubMed     Abstract available
    
    
    
95. NIZZI F, Rees M, Salzberg D, Ngwube A, et al
    Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange.
    Transfusion. 2020 Sep 5. doi: 10.1111/trf.16064.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: